| Metric | Q1'26 | Q2'26 | Change |
|---|---|---|---|
| Module production (G1 Dallas) | 683 MW | 935 MW | +37% QoQ, second-highest quarter on record |
| Adjusted EBITDA (as reported) | $9.1M record | $10.7M, incl. $24M one-time refund received after Q-end | Headline up but core EBITDA swung to roughly -$13M |
| Gross margin | 17% | 19.5%, '+300bps vs 1Q' per mgmt | Math doesn't reconcile (17%+300bps=20%, not 19.5%) |
| Cash, cash equivalents & restricted cash | $176M net proceeds raised in April convert | $149M at quarter end | Cash burn running well ahead of raises despite $176M infusion |
| Remaining G2 Phase 1 capex | ~$225M | up to $250M | Capex estimate crept +11% even after two capital raises |
| G2 first cell production timeline | Q4 2026, 'on schedule' | Q1 2027 | One-quarter slip, not acknowledged as a miss |
| 2026 production/sales guidance range | 3.1-4.2 GW, unchanged | 3.1-4.2 GW unchanged, 'near the high end' | Range held, trending to top end |
| Capital raised via convertible notes | $176M net proceeds (April offering) | additional $120M private placement (July/August) | Third dilutive raise within two quarters |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.